DaVita Clinical Research® Leadership
Fostering stability, growth, and a commitment to new clinical research innovations, the DaVita Clinical Research® team is dedicated to advancing the knowledge and practice of clinical research with a unique perspective that only a provider-based clinical research organization can provide.
Vice President, General Manager
Amy Young has been a vital part of DCR bringing deep experience in the execution of research required to bring new therapies to market. Direct experience in the care of chronically ill patients brings essential knowledge in developing and delivering trials in specialty patient populations. After receiving a B.A. in biology with a minor in chemistry, cum laude, from Augsburg College, she joined DCR holding posts with increasing responsibilities. Ms. Young has experience in the areas of strategy, leadership, operations, clinical trial conduct, renal patient populations and clinical services. She holds a CCRC from the Association of Clinical Research Professionals.
Harry Alcorn, Jr., Pharm.D.
Early Clinical Scientific Officer
As Early Clinical Scientific Officer at DCR, Dr. Alcorn is responsible for clinical conduct and pharmacy operations in the research unit and plays an active role in the design and implementation of research for DCR. In addition, he also designed and created the U.S. Renal Network, the first network of Phase I renal research sites in the U.S. and developed DCR’s site management organization (SMO) for clinical trials. Today, DCR’s clinical network comprises over 120 physicians at over 180 sites. Prior to joining DCR, Dr. Alcorn was director of clinical programs for GalaGen, Inc., and vice president of clinical programs/marketing at In Home Health, Inc. Dr. Alcorn is a clinical assistant professor at Virginia Commonwealth University School of Pharmacy and is on the adjunct clinical faculty at the University of Colorado, the University of Minnesota, Creighton University, and the University of Nebraska Medical Center. He received his undergraduate degree in pharmacy from Creighton University and his Pharm.D. from the University of Nebraska Medical Center.
Vice President and Medical Director of Health Economics and Outcomes Research
Prior to joining DCR, he was a faculty member at Harvard Medical School and the Brigham and Women’s Hospital, where he directed an active clinical research group focusing on chronic kidney disease, pharmacoepidemiology, and pharmacoeconomics, and dialysis outcomes epidemiology, as well as the hospital’s dialysis service. He has served on the American Society of Nephrology’s Dialysis Advisory Group and its Comparative Effectiveness Taskforce. He has published over 70 peer reviewed publications. He serves on editorial boards at the Journal of the American Society of Nephrology and the American Journal of Kidney Diseases. He completed medical school, internal medicine training, and nephrology specialty training at the University of Pennsylvania. Later, he earned a Master of Science degree in Clinical Epidemiology and served as faculty at University of Pennsylvania.
Vice President, Commercial Development
Kevin Goudreau brings over 25 years of experience in the life sciences industry with positions of increasing responsibility at two of the industry leaders, Covance and Primedica Corporation. He has specific experience in the creation, development, and management of both North American and global sales organizations. Prior to joining DaVita Clinical Research (DCR), Mr. Goudreau was global director of sales for clinical pharmacology and early clinical development at Covance, having previously held positions as global director of sales for both clinical pharmacology and as the director of strategic accounts. He also held a number of posts at Primedica Corporation, including director of business development and sales administration manager. Mr. Goudreau received a B.A. in biology, as well as an MBA from Anna Maria College in Paxton, MA.
Vice President, Early Clinical Research
Chad Jaeger is an experienced clinical research executive whose professional background includes 17 years in the clinical and biopharmaceutical industry. He brings a unique combination of both operational execution and business development experience in early clinical research. As a senior leader at two of the industry leaders, Covance, Inc and MDS Pharma Services, he successfully managed multiple locations, developed and implemented successful integration and operation plans, and executed successful growth strategies. Prior to joining DaVita Clinical Research (DCR), Mr. Jaeger was a Senior Account Executive for clinical pharmacology and early clinical development at Covance, having previously held positions as Regional Director of Clinical Operations. He was also a member of the MDS Pharma Services management team for 7 years. Mr. Jaeger received a Bachelor of Science from the University of Nebraska-Lincoln and is an active member of ASCPT.
Mahesh Krishnan, M.D., MPH, FASN
Vice President, Clinical Research
Dr. Mahesh Krishnan’s invaluable industry knowledge includes the well-documented areas of internal medicine, epidemiology, nephrology, public health, the business of healthcare, health economics, and health policy. Prior to joining DCR, Dr. Krishnan held posts as the executive director of medical policy and global health economics and as the executive director of medical affairs at Amgen, Inc. He was also founder and managing partner of the Clinical Consulting and Research Center in Fairfax, Virginia. Widely published on a broad range of topics, Dr. Krishnan is on the editorial board of Nephrology News and Issues and is a member of the board of the Amgen Foundation. He received his MD from Thomas Jefferson University and a master’s in public health from John Hopkins University. He has an MBA in medical services management from the John Hopkins Carey School of Business.
Allen R. Nissenson, M.D., FACP, FASN, FNKF
Chief Medical Officer
Dr. Nissenson is Chief Medical Officer of DaVita Inc. and an Emeritus Professor of Medicine at the David Geffen School of Medicine at UCLA, where he served as Director of the Dialysis Program and Associate Dean. A past president of the National Anemia Action Council (NAAC) and chair of the Southern California ESRD Network, Dr. Nissenson also consulted for the Rand Corporation and Pacificare on the development of capitation models for ESRD and served on the Dialysis Outcomes Quality Initiative of the National Kidney Foundation. He is the author of two dialysis textbooks, both in their fourth editions, and was the founding editor-in-chief of Advances in Renal Replacement Therapy. He has over 640 publications in the field of nephrology, dialysis, anemia management, and health care delivery and policy, the latter including a seminal paper in Health Affairs on the end-stage renal disease (ESRD) program. Among his numerous honors are the President’s Award of the National Kidney Foundation, the Lifetime Achievement Award in Hemodialysis presented by the University of Missouri on behalf of the Annual Dialysis Conference, and in 2011 the AAKP Medal of Excellence Award. Dr. Nissenson received his MD from the Feinberg School of Medicine of Northwestern University.